★ Island Care, World-Class Orthopedics · A full-service orthopedic group · Oahu & Big Island News Careers Contact Patient Portal (808) 439-6201

Published

How to Choose a PRP Provider in Hawaii: 8 Questions to Ask

How to Choose a PRP Provider in Hawaii: 8 Questions to Ask

Two clinics can both advertise platelet-rich plasma (PRP) and still deliver very different treatments. The diagnosis, platelet dose, preparation method, injection accuracy, and follow-up plan all matter. If you are comparing PRP providers in Honolulu, elsewhere on Oahu, or on Hawaii Island, the best question is not just “How much does one injection cost?” It is “What exactly am I receiving, why is it appropriate for my condition, and how will you know whether it helped?”

PRP is prepared from a sample of your own blood. Processing concentrates platelets, which carry signaling molecules involved in healing and inflammation. It is being studied for knee osteoarthritis and several tendon problems, but it is not one standardized medication. Here are eight practical questions to ask before scheduling treatment.

1. Does the clinician understand my diagnosis and the PRP research?

A careful PRP consultation starts with a diagnosis, not a syringe. A clinician should examine you, review any appropriate imaging, and explain whether your pain comes from arthritis, a tendon, a ligament, a nerve, or something else. The same PRP preparation may not be right for every problem.

For knee osteoarthritis, studies suggest some patients may experience less pain and better function, but results are inconsistent. The American Academy of Orthopaedic Surgeons guideline states that PRP may help, with a limited strength of recommendation. The American College of Rheumatology/Arthritis Foundation guideline recommended against PRP for knee and hip osteoarthritis, in part because preparations and techniques vary. And the large RESTORE randomized trial did not find better knee pain relief or cartilage preservation than saline at 12 months.

An informed clinician should be able to explain those differences rather than promising that PRP always works. For severe arthritis, mechanical symptoms, substantial deformity, or a different source of pain, exercise-based therapy, medications, bracing, other injections, or surgery may be more appropriate.

2. How many platelets are actually delivered?

A useful question is about total platelet dose, not merely how many times the blood was concentrated. Platelet dose depends on both the concentration and the final volume injected. A small syringe labeled “10 times concentration” does not automatically deliver more total platelets than a larger syringe at a lower concentration.

For example, a final product containing one million platelets per microliter, injected in a 5-milliliter volume, delivers approximately five billion platelets. Starting platelet counts, processing losses, white-cell content, and the number of injections also affect the comparison. Not every clinic measures the final product for every patient, so ask what is actually measured and what is an estimate based on the system.

Why does dose come up so often? In a 2024 randomized trial of early knee arthritis, the group receiving about 5.6 billion platelets did better on several symptom measures than a group receiving about 2.8 billion. A 2025 systematic review also found that studies with favorable knee arthritis results tended to deliver more platelets than studies without a positive result.

But more is not automatically better without limit. A separate 2025-published dose-category meta-analysis of 32 trials found that the middle category, roughly 5 to 10 billion platelets, showed some of the strongest comparative improvements. That result does not establish one ideal dose for every patient or every tissue. A good provider should understand dose-response research while avoiding a universal magic number.

Ask: “What total platelet dose does your protocol aim for, and how do you estimate or verify it?“

3. Do they explain the difference between PRP formulations?

PRP products differ in more than platelet counts. Some contain relatively few white blood cells (leukocyte-poor PRP), while others retain more (leukocyte-rich PRP). Red-cell contamination, the processing system, the blood volume drawn, and handling can all change the final mixture.

A formulation studied in knee osteoarthritis is not automatically the preferred formulation for an injured tendon or ligament. The clinician should explain why a particular preparation suits your condition and should be able to discuss the scientific uncertainty. “Our kit is the best” is not a substitute for a medical explanation.

Ask: “Is your PRP leukocyte-poor or leukocyte-rich, why did you choose it for me, and what do you do to control preparation quality?“

4. Will the injection be guided by ultrasound or other appropriate imaging?

The prepared material should reach the intended target. Real-time ultrasound guidance allows a trained clinician to identify tissue, see the needle approach, and adjust placement. This can be particularly useful for tendons, small or deep targets, and injections where the surrounding anatomy matters. In selected situations, fluoroscopy or another imaging method may be more appropriate.

Accuracy matters, but be precise about what the research says. A 2024 systematic review of randomized trials found benefits for ultrasound guidance versus landmark-guided knee injections in the studies evaluated. Those trials were about injection guidance in osteoarthritis; they do not prove that ultrasound specifically makes every PRP formulation biologically more effective. Some straightforward joint injections can also be placed accurately with landmarks in experienced hands.

Ask: “Will you use ultrasound or other image guidance for my injection? If not, how will you confirm the target?“

5. Does the clinician understand the plasma proteins left after PRP preparation?

When blood is processed, a platelet-rich fraction is collected and another fraction is often called platelet-poor plasma (PPP). The word “poor” refers to its platelet content, not to an absence of proteins.

PPP contains naturally occurring plasma proteins. One of particular interest is alpha-2-macroglobulin (A2M), a protein that can inhibit certain protein-degrading enzymes. Other plasma components include proteins such as insulin-like growth factor 1 (IGF-1), albumin, and fibrinogen. With additional processing, selected proteins in PPP may be concentrated into a smaller fluid volume. This is different from merely increasing platelet concentration.

A 2025 laboratory study showed that a particular filtration process could concentrate active A2M and affect some other protein concentrations in PPP. That is encouraging laboratory science, not proof that adding protein-rich PPP improves patient outcomes. Different devices may retain different proteins, and clinical results must be tested for each approach. One randomized clinical comparison of A2M-rich concentrate did not demonstrate superiority over PRP or corticosteroid treatment at 12 weeks.

This is worth discussing with a knowledgeable provider, but extra plasma-protein processing is not a proven requirement for good PRP care.

Ask: “Can you explain whether you use the PPP fraction, which proteins your method is intended to retain, and what patient-outcome evidence supports that choice?“

6. Is the preparation and injection process medically appropriate and safe?

Ask who draws the blood, who prepares the PRP, how sterile technique is maintained, and who performs the injection. A legitimate medical process includes review of relevant health conditions and medicines, explanation of expected post-injection soreness, and a plan if symptoms worsen. Do not stop blood thinners or other prescribed drugs on your own; the treating clinician should coordinate medication instructions with the prescribing professional when needed.

PRP injections can cause temporary pain, swelling, and irritation. Bleeding, infection, and injury to nearby tissue are uncommon but important possibilities. In a 2025 meta-analysis of knee-arthritis trials, reported post-injection complications were usually mild or moderate, but they were more frequent than after saline injections. Seek prompt medical assessment for increasing redness, fever, severe or escalating pain, or unusual swelling after an injection.

Ask: “Who performs the procedure, how do you manage risks, and whom should I contact if I have a problem afterward?“

7. What is the plan beyond the injection?

A useful treatment plan specifies what improvement would look like. That might be easier stair climbing, better tolerance of walking, improved participation in rehabilitation, or a lower pain score. A clinician should explain a realistic follow-up interval, activity modification, and whether structured physical therapy is appropriate.

PRP should not replace a well-designed rehabilitation program when the underlying problem needs strengthening, load management, or movement retraining. At Pacific Bone & Joint, physical therapy and rehabilitation can be part of a broader nonsurgical treatment plan when appropriate.

Ask: “What should I do afterward, how will we measure progress, and what is the next option if PRP does not help?“

8. Are the price, alternatives, and expected benefits clear?

Price matters because PRP is often an out-of-pocket service. Ask whether the quoted fee includes evaluation, preparation, ultrasound when appropriate, the injection itself, and follow-up. Ask how many injections are recommended and why. A lower price may reflect a different product or service, while a higher price does not guarantee better outcomes.

Be cautious about claims that PRP will regrow lost cartilage, cure arthritis, or definitely prevent surgery. Those outcomes are not established for routine care. Good counseling should include nonsurgical alternatives and an honest discussion of when surgery or another evaluation might make more sense.

A quick PRP provider checklist to bring to your visit

  • What diagnosis am I treating, and what evidence supports PRP for it?
  • What is the estimated total platelet dose per injection, not just the concentration multiple?
  • Is the formula leukocyte-poor or leukocyte-rich, and why?
  • Will you use ultrasound or other appropriate guidance to reach the target?
  • Is the processing sterile, and who prepares and injects the PRP?
  • Is PPP discarded, used, or specially processed to concentrate proteins such as A2M? What evidence supports that decision?
  • What benefits are realistic for my condition, and how will we measure them?
  • What is included in the cost, and what happens if treatment fails?

Looking for a PRP consultation in Hawaii?

The goal is the right treatment for the right diagnosis, prepared thoughtfully and delivered accurately. If you are exploring options, read more about PRP injections at Pacific Bone & Joint and bring your questions to the appointment. You deserve a clinician who can explain both the science and its limits.

Schedule a PRP consultation to discuss your diagnosis, platelet-dose strategy, image guidance, and whether additional plasma-protein processing is relevant to your goals.

Sources and further reading

This is general patient education, not individual medical advice. Your clinician should discuss whether PRP or another treatment fits your diagnosis and circumstances.

Dr. Paul Norio Morton, MDWritten and edited by Paul Norio Morton, MD, FAAOS, FAAHKS  ·  Board-certified orthopedic surgeon · Updated October 20, 2026

This article is educational and is not a substitute for medical advice. Individual results vary.

Questions about your care?

Schedule Appointment → Call (808) 439-6201

Many orthopedic problems improve with physical therapy alone. Learn about PB&J Physical Therapy · Find care near you

Call Schedule Appointment